(Q45800956)

16 December 2017

reason for preferred rank

title

Induction of epstein-barr virus by a new tumor promoter, teleocidin, compared to induction by TPA (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

13 September 2023

Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

13 September 2023

author name string

H. Yamamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

T. Katsuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

Y. Hinuma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

H. Hoshino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

M. Miwa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

H. Fujiki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

T. Sugimura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274809

13 September 2023

language of work or name

English

0 references

publication date

1 August 1981

1 reference

16 December 2017

15 August 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6274809

full work available at URL

13 September 2023

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910280203

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910280203

13 September 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

International Journal of Cancer

13 September 2023

published in

1 reference

16 December 2017

volume

28

1 reference

16 December 2017

page(s)

125-129

1 reference

16 December 2017

issue

2

1 reference

16 December 2017

SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS.

cites work

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism

13 September 2023

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells.

13 September 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

A possible naturally occurring tumor promoter, teleocidin B from Streptomyces

13 September 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

13 September 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints)

13 September 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine

13 September 2023

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Phorbol esters from croton oil chemical nature and biological activities

13 September 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line

13 September 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Aggregation of human lymphoblastoid cells by tumor-promoting phorbol esters and dihydroteleocidin B

13 September 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents

13 September 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Effect of the diterpene ester TPA on Epstein-Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines

13 September 2023

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Characteristics of cell lines derived from human leukocytes transformed by different strains of epstein-barr virus

13 September 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.

13 September 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

13 September 2023

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line.

13 September 2023

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

13 September 2023

19

35

1662

O'Brien

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester

13 September 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Cell-killing by Epstein-barr virus: Analysis by colony inhibition procedure

13 September 2023

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Activation of latent Epstein–Barr virus by antibody to human IgM

13 September 2023

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

13 September 2023

25

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Enhancement of outgrowth of EB virus-transformed cells from normal human peripheral blood by a tumor promoter, TPA

13 September 2023

26

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Retinoic acid inhibition of Epstein-Barr virus induction

13 September 2023

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Tumour promoter TPA enhances transformation of human leukocytes by Epstein–Barr virus

13 September 2023

28

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture

13 September 2023

29

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Tumor initiators and promoters in the induction of Epstein—Barr virus

13 September 2023

30

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

13 September 2023

31

1 reference

https://api.crossref.org/works/10.1002/IJC.2910280203

13 September 2023

Identifiers

1 reference

16 December 2017

1 reference

16 December 2017